Skip to main content

Advertisement

Table 2 Patients’ demographic information and TRG

From: The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer

Study population
Gender
 Male 52
 Female 12
 Age, years 59.1 ± 7.9
Clinical T-stage
 T1 2
 T2 15
 T3 42
 T4 5
Clinical N-stage
 No 32
 N1 15
 N2 15
 N3 2
Type
 SCC 59
 AC 2
 ASC 3
Tumor Regression Grade
 1 4
 2 4
 3 7
 4 11
 5 38